[Trimethoprim-oxolinic acid combination. In vitro interaction, bioavailability and clinical use].
作者信息
Foresta P, Genedani S, Castelli M
出版信息
G Ital Chemioter. 1981 Jan-Dec;28(1-2):21-7.
PMID:7347702
Abstract
摘要
相似文献
1
[Trimethoprim-oxolinic acid combination. In vitro interaction, bioavailability and clinical use].[甲氧苄啶-恶喹酸联合制剂。体外相互作用、生物利用度及临床应用]
G Ital Chemioter. 1981 Jan-Dec;28(1-2):21-7.
2
Comparison of oxolinic acid, trimethoprim, and trimethoprim-sulfamethoxazole in the treatment and long-term control of urinary tract infection.恶喹酸、甲氧苄啶及甲氧苄啶-磺胺甲恶唑在治疗和长期控制尿路感染中的比较。
Curr Ther Res Clin Exp. 1976 Nov;20(5):645-54.
3
[Studies on the interaction of nalidixic acid and oxolinic acid].
Orv Hetil. 1975 Dec 14;116(50):2947-8.
4
[Treatment with oxolinic acid of urinary tract infections].
Minerva Med. 1979 Jul 21;70(33):2333-9.
5
6
7
Proceedings: a bacteriological and clinical assessment of a new drug-oxolinic acid.
Br J Urol. 1975 Apr;47(2):233-4.
8
Drug therapy reviews: oxolinic acid.
Am J Hosp Pharm. 1979 Aug;36(8):1077-9.
9
Trimethoprim. Pharmacology, antimicrobial activity and clinical use in urinary tract infections.
Ann Clin Res. 1978;10 Suppl 22:1-39.
10
[Oxolinic acid treatment of urinary sepsis in patients with renal insufficiency].[氧氟沙星治疗肾功能不全患者的尿源性脓毒症]
Minerva Med. 1979 Feb 25;70(9):675-8.
Zotero 插件